Ilkka Vauhkonen
Novo Nordisk (Finland)(FI)
Publications by Year
Research Areas
Adipose Tissue and Metabolism, Pancreatic function and diabetes, Ovarian function and disorders, Adipokines, Inflammation, and Metabolic Diseases, Diabetes Management and Research
Most-Cited Works
- → Dominantly inherited hyperinsulinism caused by a mutation in the sulfonylurea receptor type 1(2000)275 cited
- → Multiple Abnormalities in Glucose and Energy Metabolism and Coordinated Changes in Levels of Adiponectin, Cytokines, and Adhesion Molecules in Subjects With Metabolic Syndrome(2004)264 cited
- → Endocrine and Metabolic Effects of MetforminVersusEthinyl Estradiol-Cyproterone Acetate in Obese Women with Polycystic Ovary Syndrome: A Randomized Study1(2000)235 cited
- → Insulin sensitivity, insulin secretion, and metabolic and hormonal parameters in healthy women and women with polycystic ovarian syndrome(2000)225 cited
- → A new subtype of autosomal dominant diabetes attributable to a mutation in the gene for sulfonylurea receptor 1(2003)182 cited
- → MetforminVersusEthinyl Estradiol-Cyproterone Acetate in the Treatment of Nonobese Women with Polycystic Ovary Syndrome: A Randomized Study(2003)181 cited
- → Defects in insulin secretion and insulin action in non-insulin-dependent diabetes mellitus are inherited. Metabolic studies on offspring of diabetic probands.(1998)159 cited
- → The C-174G Promoter Polymorphism of the IL-6 Gene Affects Energy Expenditure and Insulin Sensitivity(2003)146 cited
- → Electrocardiographic Alterations during Hyperinsulinemic Hypoglycemia in Healthy Subjects(2008)110 cited
- → Power spectral analysis of heart rate variability during hyperinsulinemia in nondiabetic offspring of type 2 diabetic patients: evidence for possible early autonomic dysfunction in insulin-resistant subjects.(1999)97 cited